Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study (Q50754954)
scientific article published on April 1, 1998
Language:
(P31) (Q13442814)
(P304) 1519-1525
(P407) (Q1860)
(P433) 4
(P478) 16
(P577) Wednesday, April 1, 1998
Wednesday, April 1, 1998
(P921) (Q29496)
(Q264118)
(P953) http://intl.jco.org/cgi/content/abstract/16/4/1519
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.4.1519
(P1433) (Q400292)
(P1476) "Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study" (language: en)
(P2093) K. Laczika
M. Novak
B. Hilgarth
M. Mitterbauer
G. Mitterbauer
A. Scheidel-Petrovic
C. Scholten
R. Thalhammer-Scherrer
S. Brugger
F. Keil
I. Schwarzinger
O. A. Haas
K. Lechner
U. Jaeger
other details
description scientific article published on April 1, 1998

External Links